2002
DOI: 10.1046/j.1440-1746.17.s4.15.x
|View full text |Cite
|
Sign up to set email alerts
|

Immunological tolerance: the liver effect

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 17 publications
0
29
0
Order By: Relevance
“…Induction of tolerance of heart grafts in the setting of a concomitant liver graft has indeed been well demonstrated in animal models. 36,37 Lower acute rejection rates have been reported for combined heart-lung transplantation in humans when compared with single-…”
Section: Discussionmentioning
confidence: 99%
“…Induction of tolerance of heart grafts in the setting of a concomitant liver graft has indeed been well demonstrated in animal models. 36,37 Lower acute rejection rates have been reported for combined heart-lung transplantation in humans when compared with single-…”
Section: Discussionmentioning
confidence: 99%
“…Excellent reviews are available on the role of the liver in the development of immune tolerance and the antigen-specific immune response (e.g. Calne, 2000;Knolle and Gerken, 2000;Seki et al, 2000). This section focusses on the hepatic acute phase response.…”
Section: The Immune Organ Livermentioning
confidence: 99%
“…The need for reliable immune monitoring programs is evident from the finding of recent prospective drug weaning trials which showed that patients in these trials experienced more rejections and developed more sclerosis of the transplant than patients on conventional immunosuppression [9,[80][81][82]. It is well known that liver transplant recipients are more receptive to tolerance induction protocols than recipients of other solid organ transplants and that drug weaning procedures are more successful after liver transplantation [14,47,83]. In all probability, successful immune monitoring programs will be first developed for liver transplant recipients.…”
Section: Limitations Of Immune Monitoring Studiesmentioning
confidence: 99%